FDA approves new rare disease drug within 6 months

The FDA will approve at least one new rare disease drug within six months of Makary's departure, reversing recent controversial rejections. This aligns with Trump's push to streamline rare disease drug approvals and reduce animal testing, despite past internal resistance.

Implied probability (Yes)

70%